SCHEMBL29434093

SCHEMBL29434093

O=Cc1cc(-c2cc(Cl)cc(N3CCOCC3)n2)ccn1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMG1 Q96Q15 5/20 0.47
▸ CDK1 P06493 2/20 0.45
▸ CDK2 P24941 2/20 0.45
▸ PIK3CA P42336 10/20 0.44
▸ AKT1 P31749 5/20 0.44
▸ MAPT P10636 2/20 0.42
▸ TSHR P16473 1/20 0.42
▸ MAPK1 P28482 1/20 0.42
▸ NPSR1 Q6W5P4 1/20 0.42
▸ HSD17B10 Q99714 1/20 0.42
▸ MTOR P42345 4/20 0.42
▸ MEN1 O00255 1/20 0.42
▸ NPC1 O15118 1/20 0.42
▸ RAB9A P51151 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ ATR Q13535 1/20 0.41
▸ ATRIP Q8WXE1 1/20 0.41
▸ CYP1A2 P05177 1/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ CYP2C9 P11712 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24766052 1.00 SMG1 (0.47) SMG1CDK1CDK2PIK3CAAKT1
SCHEMBL24766582 0.80 SMG1 (0.48) SMG1CDK1CDK2PIK3CAAKT1
SCHEMBL29434171 0.80 SMG1 (0.48) SMG1CDK1CDK2PIK3CAAKT1
SCHEMBL24766047 0.79 MAPT (0.49) MAPTNPSR1MEN1NPC1RAB9A
SCHEMBL29434142 0.74 CDK1 (0.52) SMG1CDK1CDK2PIK3CAAKT1
SCHEMBL24766835 0.74 CDK1 (0.52) SMG1CDK1CDK2PIK3CAAKT1
SCHEMBL17204101 0.72 MAPT (0.61) MAPTTSHRMAPK1NPSR1HSD17B10
SCHEMBL3596552 0.71 MAPT (0.49) MAPTTSHRMAPK1NPSR1HSD17B10
SCHEMBL24766055 0.70 PIM1 (0.49) MAPTTSHRMAPK1NPSR1HSD17B10
SCHEMBL24766568 0.70 ATR (0.57) ATRATRIP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022060996-A1 INHIBITORS OF RAF KINASES KINNATE BIOPHARMA INC. (US) 2022-03-24 — — WO disclosed
Send feedback